KOSDAQChemicals357550

Sukgyung AT

₩28,450▼ 1.22%2026-11-18 close
Market Cap
₩155.2B
Turnover
₩75,996,700
Volume
2.7K
Shares out.
5.5M
PER
43.6×
PBR
3.5×
EPS
₩684
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Dental and toner growth amid widening earnings swings

Sales kept climbing into mid-2026, yet net income attributable to controlling shareholders fell to KRW 32.7 million in the third quarter, so growth and quarterly earnings stability are diverging.

  1. 1

    Annual sales rose to KRW 17.5 billion in 2025, up 27.0% year on year, and operating profit rebounded to KRW 3.9 billion, up 93.0% from the 2024 low.

  2. 2

    Of cumulative third-quarter 2026 sales of KRW 14.8 billion, dental materials BAG and SRG contributed KRW 2.8 billion, up 30.2% year on year, and silica products contributed KRW 1.2 billion, up 28.7%.

  3. 3

    Quarterly operating profit was KRW 1.28 billion in Q1 2026, KRW 1.28 billion in Q2 and KRW 1.59 billion in Q3, while net income attributable to controlling shareholders dropped to KRW 32.7 million in Q3.

  4. 4

    Depreciation and fixed costs at Gimje Plant No.3 are the main factor the company has cited behind quarterly earnings swings.

  5. 5

    New materials for semiconductor packaging, transformer vibration damping and solid-state electrolytes are mostly in customer evaluation, and a Korean research house presented a Positive view and a KRW 60,000 target price in a November 12, 2026 report.

02

Business structure

Sukgyung AT is a nano-materials specialist that started in 1994 as Sukgyung Chemical, and it holds in-house four core technologies covering particle size and shape control, dispersion, surface treatment and purification to develop and mass-produce functional materials.

Its core businesses are dental materials and silica-based toner external additives. Dental materials include YbF3, which enhances X-ray contrast, and BAG and SRG, which improve mechanical strength, and a November 12, 2026 research report from a Korean brokerage identified dental materials as the largest revenue share.

Cumulative third-quarter 2026 sales of BAG and SRG reached KRW 2.8 billion, up 30.2% year on year, and silica product sales reached KRW 1.2 billion, up 28.7%.

Among dental customers, the supply of filler material to a US dental 3D printing solutions company is expected to generate recurring demand as that customer expands overseas equipment sales, the same report noted.

Toner external additives are supported by new customers in China and mass-production evaluations at US and Japanese customers. The cumulative export share reached 65.7% in the first three quarters of 2026, up from 62.4% a year earlier.

Production sits across the headquarters plant, Yeongam Plant No.2 and Gimje Plant No.3, and Yeongam Plant No.2 finished restoration after a May 2025 fire. Gimje Plant No.3 moved into full operation from Q1 2026.

In certain product lines the company targets strontium titanate markets long dominated by Japanese producers, using a zinc stannate-based perovskite material as a representative example.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩3.4B₩400M10.6%
2025Q4₩4.1B₩68,050,1081.7%
2026Q1₩4.6B₩1.3B28.0%
2026Q2₩5.2B₩1.3B24.7%
2026Q3₩5.1B₩1.6B31.2%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩12.3B₩4.7B₩4.3B38.1%14.4%12.0%
2023₩12.2B₩3.5B₩3.5B28.7%9.6%11.6%
2024₩13.8B₩2B₩4.3B14.6%10.9%23.5%
2025₩17.5B₩3.9B₩3.8B22.2%8.6%23.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

On a reported annual basis, sales were KRW 12.3 billion in 2022, KRW 12.2 billion in 2023 (down 1.2%), KRW 13.8 billion in 2024 (up 13.3%) and KRW 17.5 billion in 2025 (up 27.0%). Sales grew in 2024 and 2025 after the 2023 low, and 2025 was the largest year of 2022 to 2025.

Operating profit fell from KRW 4.71 billion in 2022 to KRW 3.5 billion in 2023 (down 25.6%) and KRW 2.02 billion in 2024 (down 42.3%), before recovering to KRW 3.9 billion in 2025 (up 93.0%). Operating margin moved from 38.1% in 2022 to 28.7% in 2023, 14.6% in 2024 and 22.2% in 2025.

The company attributed the 2025 margin improvement to higher sales easing fixed-cost pressure and lower one-time selling and administrative expenses.

Net income attributable to controlling shareholders was KRW 4.29 billion in 2022, KRW 3.45 billion in 2023, KRW 4.34 billion in 2024 and KRW 3.8 billion in 2025, and the 12.4% decline in 2025 reflects the absence of a one-time tax refund booked in the 2024 closing.

Equity at year-end 2025 was KRW 44.1 billion, all attributable to controlling shareholders, and total liabilities were KRW 10.2 billion, with the debt ratio at 23.5% in 2024 and 23.2% in 2025.

Operating cash flow was KRW 5.5 billion in 2022, KRW 3.03 billion in 2023, KRW 4.4 billion in 2024 and KRW 5.35 billion in 2025.

Quarterly sales went from KRW 3.42 billion in Q3 2025 to KRW 4.08 billion in Q4 (up 19.3% quarter on quarter), KRW 4.56 billion in Q1 2026 (up 11.9%), KRW 5.17 billion in Q2 (up 13.3%) and KRW 5.11 billion in Q3 (down 1.2%, but up 49.4% year on year).

Q4 2025 operating profit fell 81.3% quarter on quarter to KRW 68.05 million, and the company tied this to Gimje Plant No.3 depreciation and operating costs in the second half.

Q1 2026 operating profit rose to KRW 1.28 billion, up 1,776.1% from the prior quarter, followed by KRW 1.28 billion in Q2 and KRW 1.59 billion in Q3. Net income attributable to controlling shareholders peaked at KRW 1.4 billion in Q1 2026, then fell to KRW 1.13 billion in Q2 and KRW 32.7 million in Q3.

On a cumulative third-quarter 2026 basis, the company cited higher income tax expense and foreign-currency-related losses as drags on net income. The last four reported quarters total KRW 3.73 billion in net income attributable to controlling shareholders.

05

Industry analysis

Sukgyung AT draws demand from several end markets. Dental 3D printing materials are tied to overseas equipment sales, while toner external additives move with the output of printer toner makers.

In semiconductor packaging, the company said in February 2026 that high-function silica fillers aimed at warpage control in larger AI server and high-performance computing packages are under evaluation at three overseas and two domestic customers.

In Q1 2026 it also said underfill materials for semiconductor packaging were being tested with major Japanese customers. In transformer noise, a November 12, 2026 research report noted that Loudoun County in Virginia is pursuing revisions to rules on low-frequency and tonal noise.

The same report said nano damping materials that reduce core vibration are in field trials with major domestic transformer makers. Refrigerator insulation materials are also in trials with a domestic appliance maker.

Competitively, Sukgyung AT differs in scale from large petrochemical and battery-materials groups and operates as a small to mid-sized materials company building customer qualifications in niche functional materials such as dental and toner products.

The timing of contributions from new materials appears to depend more on individual customer qualification schedules than on the broader chemical cycle.

06

Outlook

In its February 2026 release, the company said higher value-added sales from cosmetic materials, hollow silica and semiconductor packaging materials would be reflected gradually during 2026.

Alongside its third-quarter 2026 results, the company said shipments of major overseas customers' orders are concentrated in the fourth quarter, with additional sales growth expected mainly in dental materials.

Gimje Plant No.3 is pursuing automation systems for mass-production capacity and efficiency, and additional expansion and capacity plans are under review. The company had planned to supply solid-state electrolyte samples to major domestic customers in June 2026 and to broaden customer engagement afterward.

Follow-on progress for refrigerator insulation materials depends on the results of customer field tests. The November 12, 2026 research report estimated 2026 sales of KRW 19.9 billion and operating profit of KRW 5.5 billion, and 2027 sales of KRW 30.1 billion and operating profit of KRW 9 billion.

Those 2026 estimates imply roughly KRW 5.1 billion of sales in Q4 on top of cumulative third-quarter 2026 sales of KRW 14.8 billion. A treasury share acquisition through a trust agreement disclosed on October 1, 2026 reported 14,310 shares acquired.

07

Valuation

PER
43.6×
PBR
3.5×
ROE
8.4%
EPS
₩684
BPS
₩8,524
Dividend per share
₩0

Based on the current share price, price-to-book sits at a large premium to book value, which can be compared with periods when quarter-end price-to-book stayed above 5 times in the past.

Price-to-earnings is calculated on earnings that summed to KRW 3.73 billion across the last four reported quarters, so the multiple is sensitive to swings in quarterly net income. Operating profit in 2026 has remained at a high level, so the gap between operating profit and net income needs to be read together.

Cash dividend yield is effectively negligible, and shareholder returns have been delivered through a treasury share acquisition trust. A November 12, 2026 research report presented a Positive view and a KRW 60,000 target price.

The 2027 operating profit estimate of KRW 9 billion in the same report depends on the timing of new material commercialization. The key point for valuation is whether net income attributable to controlling shareholders rises back toward the level of operating profit.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Overseas dental and toner demand expanding

Cumulative third-quarter 2026 BAG and SRG sales reached KRW 2.8 billion, up 30.2% year on year, and silica product sales reached KRW 1.2 billion, up 28.7%. In Q1 2026 the company said its dental materials segment grew 48% year on year.

The cumulative export share rose to 65.7% in the first three quarters of 2026 from 62.4% a year earlier. The company also cited concentrated fourth-quarter shipments to overseas customers as a basis for further sales gains.

Evaluation pipeline for new materials

The company said high-function silica for semiconductor packaging is under applicability evaluation at three overseas and two domestic customers. Solid-state electrolyte samples were scheduled for supply to a major domestic customer in June 2026.

Transformer damping materials are in field trials with major domestic transformer makers. If these materials are commercialized, their share of higher value-added sales could grow, which bulls point to as the core case.

Operating profit recovery and a Positive brokerage view

Quarterly operating profit stayed high through 2026, at KRW 1.28 billion in Q1, KRW 1.28 billion in Q2 and KRW 1.59 billion in Q3, compared with KRW 68.05 million in Q4 2025. A Korean research house presented a Positive view and a KRW 60,000 target price in its November 12, 2026 report. The same report estimated 2027 sales of KRW 30.1 billion and operating profit of KRW 9 billion.

09

Bear factors

Sharp drop in quarterly net income attributable to controlling shareholders

Net income attributable to controlling shareholders was KRW 32.7 million in Q3 2026, down 97.1% from the prior quarter and down 96.0% year on year. It has declined for two consecutive quarters since Q2 2026.

Operating profit rose to KRW 1.59 billion over the same period, widening the gap between operating profit and net income. On a cumulative basis, the company cited higher income tax expense and foreign-currency-related losses as factors behind that gap.

Fixed-cost burden from Gimje Plant No.3

Operation at Gimje Plant No.3 raised depreciation, operating costs and production headcount costs, and Q4 2025 operating profit fell 81.3% quarter on quarter to KRW 68.05 million. Q1 2026 results also reflected higher initial fixed costs as the plant moved into full operation. If sales do not grow enough to absorb these fixed costs, quarterly earnings swings could widen.

Uncertain timing for commercializing new businesses

New materials for semiconductor packaging, refrigerator insulation, transformer damping and solid-state electrolytes remain in customer evaluation or field-trial stages.

The company itself described next-generation materials as requiring medium- to long-term development because of technical difficulty and reliability verification. The uncertain timing of sales from these materials is a bearish factor.

10

Risk factors

Customer and export concentration

Revenue depends heavily on the timing of orders and shipments from overseas customers. The cumulative export share reached 65.7% in 2026, and shipments are concentrated in Q4, so any delay could widen quarterly sales swings. Foreign-currency-related losses from exchange rate moves are also a variable for earnings.

Production facilities and fire history

A fire at Yeongam Plant No.2 in May 2025 led to restoration costs, and the company shifted production to its headquarters plant. The company said restoration is complete, but with production spread across several sites, facility operating status remains sensitive to earnings. Gimje Plant No.3 is under review for automation and expansion, which could keep investment burdens elevated.

Dependence on regulation and qualification timelines

Tighter transformer noise rules are the growth path cited in the research report, but the timing and strength of rule revisions remain undecided. Semiconductor packaging and solid-state electrolyte materials could see mass-production schedules slip depending on customer test outcomes.

If qualification of a given material is delayed, the assumptions behind brokerage estimates could also be affected.

11

What to watch next

  1. Late December 2026

    Field-test results for transformer damping materials at domestic transformer makers. The Korean research house expects test results within 2026 and possible market entry from 2027.

  2. Mid-February 2027 (based on last year's preliminary release timing)

    Preliminary 2026 annual results and whether fourth-quarter overseas shipments are reflected. This shows whether annual sales approach the research house's estimate.

  3. By March 31, 2027

    Filing of the 2026 annual business report. Full-year results are confirmed in the DART periodic report, allowing the gap between operating profit and net income to be checked against tax and foreign-currency items.

  4. Mid-May 2027 (based on last year's Q1 release timing)

    Q1 2027 results. Key points are whether sales growth absorbs Gimje Plant No.3 fixed costs and whether net income attributable to controlling shareholders recovers toward the Q1 2026 level.

12

Overall view

Sukgyung AT's operating profit recovered to KRW 3.9 billion in 2025, up 93.0%, and sales have since grown through the third quarter of 2026, led by dental materials and silica products.

However, net income attributable to controlling shareholders peaked at KRW 1.4 billion in Q1 2026, then fell to KRW 1.13 billion in Q2 and KRW 32.7 million in Q3, leaving a wide gap versus operating profit.

On a cumulative basis the company cited higher income tax expense and foreign-currency-related losses, and Gimje Plant No.3 fixed costs are seen as a backdrop to quarterly earnings swings. The bull case rests on overseas customer demand, a rising export share and progress in customer evaluations of new materials.

The bear case points to sharp quarterly net income swings, concentrated overseas shipments and uncertain timing for commercializing new materials.

A November 12, 2026 research report presented a Positive view and a KRW 60,000 target price, and its 2027 operating profit estimate of KRW 9 billion depends on when new materials are commercialized.

The next checkpoints are whether fourth-quarter overseas shipments appear in the 2026 annual business report and whether net income attributable to controlling shareholders recovers in Q1 2027.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 16 more articles and sources
  1. view.asiae.co.kr
  2. greened.kr
  3. m.news.nate.com
  4. sedaily.com
  5. m.news.nate.com
  6. core.asiae.co.kr
  7. joongangenews.com
  8. hankyung.com
  9. hankyung.com
  10. m.news.nate.com
  11. ksdaily.co.kr
  12. comp.fnguide.com
  13. news.nate.com
  14. newspim.com
  15. goinsider.kr
  16. newspim.com

Report written 2026-11-13 · Data as of 2026-11-12

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis